Tiverton Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-7,526
| Closed | -$986K | – | 753 |
|
|
2019
Q2 | $986K | Buy |
7,526
+3,859
| +105% | +$506K | 0.04% | 268 |
|
|
2019
Q1 | $496K | Buy |
3,667
+514
| +16% | +$69.5K | 0.02% | 340 |
|
|
2018
Q4 | $307K | Sell |
3,153
-648
| -17% | -$63.1K | 0.02% | 273 |
|
|
2018
Q3 | $528K | Hold |
3,801
| – | – | 0.03% | 241 |
|
|
2018
Q2 | $472K | Buy |
3,801
+1,528
| +67% | +$190K | 0.02% | 248 |
|
|
2018
Q1 | $253K | Sell |
2,273
-1,260
| -36% | -$140K | 0.02% | 286 |
|
|
2017
Q4 | $423K | Buy |
+3,533
| New | +$423K | 0.03% | 251 |
|